Timothy Kerut, MD
Allergy & Immunology · Vicksburg, MSNPI 1932130127
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,007 of the $5,010 with a category attached, or 60.0%. 20 manufacturers reported payments, led by GSK at 52.5% of the total. Reporting peaked in 2019 at $2,257 and has fallen 68.9% since, to $702 in 2025. That places this record below the midpoint for allergy & immunology clinicians in MS, where the typical reported total is $10,118.
Across 147 payments — averaging $34.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- Regeneron Healthcare Solutions, Inc.$716
- AstraZeneca$468
- Grifols USA, LLC$374
- Genentech USA, Inc.$277
- Novartis$140
- plus $404 from 14 others
What the payments were for
- Consulting fees$1,95039%
- Food & beverage$3,00760%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 38 | $2,631 |
| Regeneron Healthcare Solutions, Inc. | 31 | $716 |
| AstraZeneca | 20 | $468 |
| Grifols USA, LLC | 19 | $374 |
| Genentech USA, Inc. | 10 | $277 |
| Novartis | 8 | $140 |
| CSL Behring | 1 | $64 |
| Amgen | 2 | $47 |
| Aimmune Therapeutics, Inc. | 3 | $45 |
| Pfizer | 3 | $44 |
| Merck | 2 | $33 |
| USWM, LLC | 2 | $26 |
| Biocryst US Sales Co., LLC | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Sanofi | 1 | $20 |
| Pharming Healthcare, Inc. | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $13 |
How this compares
$5,010 in reported general payments places this provider in the 35th percentile of 28 allergy & immunology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucalaMepolizumab | 58 | $256,759 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 143 | $105,679 |
| XolairOmalizumab | 21 | $104,413 |
| Dupixent SyringeDupilumab | 26 | $102,217 |
| Spiriva RespimatTiotropium Bromide | 56 | $31,004 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 78 | $11,435 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $10,866 |
| Epinephrine | 31 | $6,307 |
| Azelastine Hcl | 170 | $4,573 |
| Arnuity ElliptaFluticasone Furoate | 14 | $3,866 |
| Wixela InhubFluticasone Propion/Salmeterol | 22 | $2,281 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 57 | $1,741 |
| Ipratropium Bromide | 53 | $1,201 |
| Fluticasone Propionate | 84 | $988 |
| Ventolin HfaAlbuterol Sulfate | 11 | $617 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKNucala, Trelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $2,631 | $377,170242 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 28 allergy & immunology providers in Mississippi.
Other allergy & immunology in Vicksburg
- Todd AdkinsJackson$226K
- Patricia StewartMadison$215K
- Daniel VenarskeJackson$156K
- Dexter WalcottJackson$154K
- Chelle WilhelmJackson$61K
- Mark MurrayDiberville$41K
- Stephen LeblancMeridian$34K
- Jennifer OlivierPicayune$24K
- Joshua PhillipsJackson$20K
- Matthew OswaltTupelo$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.